Adalimumab

Details

Files

Generic Name:

Adalimumab

Project Status:

Complete

Therapeutic Area:

Arthritis, Rheumatoid

Manufacturer:

Abbott Laboratories Limited

Brand Name:

Humira

Project Line:

Reimbursement Review

Project Number:

SR0022-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Rheumatoid

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

February 11, 2005

Recommendation:

List for patients with moderate to severe active RA who meet current drug plan for funding of infliximab or etanercept

Last Updated : September 24, 2004